Blog

The pharmaceutical industry is shifting towards a model where collaboration among brand, marketing, and account field teams is not just a nice-to-have, but a strategic imperative. As access to markets becomes increasingly complex, companies that successfully align these internal functions stand to gain a significant competitive edge. In specialty pharma, where tailored approaches are often […]

Specialty pharmacists can help patients changing payers or providers, and specialty pharmacy data helps with medication adherence strategies.

Specialty pharmacy distribution is changing as specialty drug treatments become more commonplace. Many biosimilars have entered the rare disease market, directly competing with biologics like Humira that represented breakthroughs in their time. New treatments for a wide range of conditions are also available, including biologics, cell and gene therapies for rare diseases.  Wider adoption of

Patients readily switch doctors, making medication adherence strategies difficult. Specialty pharmacy data can assist with the patient journey orchestration.

Specialty pharmacists can help patients changing payers or providers, and specialty pharmacy data helps with medication adherence strategies.

A look at pharma market insights plus regulatory news updates from the FDA and related agencies to wrap up 2023.

Marketwide benchmarking and pharma brand benchmarking provide two key perspectives on how a rare disease treatment performs.

Cell and gene therapies in development today provide real world evidence analytics for how rare diseases will be treated tomorrow.